Merck Canada has announced a collaboration with the Vector Institute in Toronto to enhance its artificial intelligence (AI) capabilities and drive innovation in healthcare. The multi-year agreement will enable Merck Canada to access Vector’s research capabilities and expertise in AI, fostering collaboration and exchange of ideas in the field of life sciences.
Through this collaboration, Merck Canada will have the opportunity to tap into Vector Institute’s extensive network of AI researchers, engineers, and startups. This interaction will facilitate the exploration of AI’s potential in transforming healthcare and delivering impactful solutions for patients in Canada and beyond.
Marwan Akar, Managing Director at Merck Canada, expressed excitement about the opportunities presented by the collaboration with the Vector Institute. He stated, Together, we will explore the potential of AI to transform the way we address healthcare challenges and deliver impactful solutions that benefit patients in Canada and beyond.
Abhishek Narayan Singh, Vice President, Data Science, at Merck, emphasized the importance of leveraging AI to improve health outcomes. As digital transformation continues to reshape healthcare, organizations like Vector play a crucial role in finding innovative ways to utilize machine learning and deep learning technologies.
Tony Gaffney, President and CEO of the Vector Institute, highlighted the significance of modern healthcare solutions for Canadians and expressed enthusiasm for welcoming Merck Canada to Vector’s sponsor community. Gaffney stated, Together with Vector, Merck’s strong commitment to innovation in health will help realize AI capabilities that can be life-changing for patients.
Merck, known as MSD outside of the United States and Canada, is a research-intensive biopharmaceutical company that strives to save and improve lives worldwide through the development of medicines and vaccines. In Canada, Merck is a leading marketer of vaccines, pharmaceuticals, and animal health products, with a strong commitment to research and development.
The Vector Institute, established in 2017, works collaboratively with industry, institutions, startups, and governments to advance AI talent and research excellence. Its aim is to drive AI-based innovation, foster economic growth, and improve the lives of Canadians. Vector’s programs provide guidance, training, and connections for industry applications, contributing to the responsible use of AI.
With this collaboration, Merck Canada and the Vector Institute are poised to make significant strides in applying AI to healthcare, paving the way for transformative solutions that benefit patients and contribute to the advancement of the industry. The partnership between the pharmaceutical giant and the leading AI research institution holds significant promise for the future of healthcare innovation in Canada and beyond.
References:
– Merck Canada. (n.d.). Retrieved from [Merck Canada website](www.merck.ca)
– Vector Institute. (n.d.). Retrieved from [Vector Institute website](https://vectorinstitute.ai/)
